Literature DB >> 15831557

Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies.

Heiko Mahrholdt1, Anja Wagner, Robert M Judd, Udo Sechtem, Raymond J Kim.   

Abstract

Non-ischaemic cardiomyopathies (NICMs) are chronic, progressive myocardial diseases with distinct patterns of morphological, functional, and electrophysiological changes. In the setting of cardiomyopathy (CM), determining the exact aetiology is important because the aetiology is directly related to treatment and patient survival. Determining the exact aetiology, however, can be difficult using currently available imaging techniques, such as echocardiography, radionuclide imaging or X-ray coronary angiography, since overlap of features between CMs may be encountered. Cardiovascular magnetic resonance (CMR) imaging has recently emerged as a new non-invasive imaging modality capable of providing high-resolution images of the heart in any desired plane. Delayed contrast enhanced CMR (DE-CMR) can be used for non-invasive tissue characterization and may hold promise in differentiating ischaemic from NICMs, as the typical pattern of hyperenhancement can be classified as 'ischaemic-type' or 'non-ischaemic type' on the basis of pathophysiology of ischaemia. This article reviews the potential of DE-CMR to distinguish between ischaemic and NICM as well as to differentiate non-ischaemic aetiologies. Rather than simply describing various hyperenhancement patterns that may occur in different disease states, our goal will be (i) to provide an overall imaging approach for the diagnosis of CM and (ii) to demonstrate how this approach is based on the underlying relationships between contrast enhancement and myocardial pathophysiology.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15831557     DOI: 10.1093/eurheartj/ehi258

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  224 in total

Review 1.  Left ventricular hypertrophy: The relationship between the electrocardiogram and cardiovascular magnetic resonance imaging.

Authors:  Ljuba Bacharova; Martin Ugander
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-11-04       Impact factor: 1.468

Review 2.  Chromosomal regulation by MeCP2: structural and enzymatic considerations.

Authors:  N J Bowen; M B Palmer; P A Wade
Journal:  Cell Mol Life Sci       Date:  2004-09       Impact factor: 9.261

3.  Correlation between ECG abnormalities and cardiac parameters in highly trained asymptomatic male endurance athletes: evaluation using cardiac magnetic resonance imaging.

Authors:  Gunnar Erz; Stefanie Mangold; Erik Franzen; Claus D Claussen; Andreas M Niess; Christof Burgstahler; Ulrich Kramer
Journal:  Int J Cardiovasc Imaging       Date:  2012-06-22       Impact factor: 2.357

4.  Delayed enhancement cardiac magnetic resonance imaging in propionic acidemia.

Authors:  Satoru Iwashima; Takamichi Ishikawa; Takehiko Ohzeki; Yusaku Endou
Journal:  Pediatr Cardiol       Date:  2010-05-19       Impact factor: 1.655

5.  Multiple old myocardial scars and new onset of myocarditis in two young patients presenting with ventricular tachycardias and dilated cardiomyopathy.

Authors:  Anamaria Wolf-Puetz; Matthias Wein; Reinhard Niehues; Marc Horlitz; Malte Kelm; Karin Klingel; Reinhard Kandolf; Rolf Michael Klein
Journal:  Clin Res Cardiol       Date:  2010-12-03       Impact factor: 5.460

Review 6.  The role of cardiac magnetic resonance imaging in the assessment of non-ischemic cardiomyopathy.

Authors:  Mouaz H Al-Mallah; Mohammad Naseem Shareef
Journal:  Heart Fail Rev       Date:  2011-07       Impact factor: 4.214

7.  [Letter re: G. Geppert et al. "Wasp sting, adrenaline injection and acute thoracic pain: an unusual case of stress-induced (tako-tsubo) cardiomyopathy" : Med Klin 2010;105:246-8].

Authors:  Detlef Michael Ringbeck
Journal:  Med Klin (Munich)       Date:  2010-10

8.  MRI differentiation of cardiomyopathy showing left ventricular hypertrophy and heart failure: differentiation between cardiac amyloidosis, hypertrophic cardiomyopathy, and hypertensive heart disease.

Authors:  Minako Takeda; Yasuo Amano; Masaki Tachi; Hitomi Tani; Kyoichi Mizuno; Shinichiro Kumita
Journal:  Jpn J Radiol       Date:  2013-08-31       Impact factor: 2.374

9.  Early non-invasive diagnosis and treatment of acute eosinophilic myopericarditis by cardiac magnetic resonance.

Authors:  Eun Young Kim; Sung-A Chang; Yoo-Kyung Lee; Jin-Oh Choi; Yeon Hyeon Choe
Journal:  J Korean Med Sci       Date:  2011-10-27       Impact factor: 2.153

10.  T1 Mapping in cardiomyopathy at cardiac MR: comparison with endomyocardial biopsy.

Authors:  Christopher T Sibley; Radwa A Noureldin; Neville Gai; Marcelo Souto Nacif; Songtao Liu; Evrim B Turkbey; James O Mudd; Rob J van der Geest; João A C Lima; Marc K Halushka; David A Bluemke
Journal:  Radiology       Date:  2012-10-22       Impact factor: 11.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.